Breast Cancer - Treatment Options, Symptoms, Causes & Diagnosis from MedifocusHealth

Breast Cancer > What Your Doctor is Reading About Breast Cancer > General Interest Articles

General Interest Articles

1. Hereditary breast cancer: part II. Management of hereditary breast cancer: implications of molecular genetics and pathology.

Author: Silva E; Gatalica Z; Snyder C; Vranic S; Lynch JF; Lynch HT;
Institution: Surgical Oncology Department, Creighton University Medical Center Cancer Center, Omaha, Nebraska 68178, USA.
Journal: Breast J. 2008 Jan-Feb;14(1):14-24. Epub 2007 Dec 11.
Abstract URL: Click here to view abstract

2. Physical exercise and quality of life in breast cancer survivors.

Author: Valenti M; Porzio G; Aielli F; Verna L; Cannita K; Manno R; Masedu F; Marchetti P; Ficorella C;
Institution: Biostatistics, Epidemiology Unit, Faculty of Movement, Sport Science, Department of Medicine, Public Health, University of L'Aquila. L'Aquila, Italy. marco.valenti@cc.univaq.it
Journal: Int J Med Sci. 2008 Jan 15;5(1):24-8.
Abstract URL: Click here to view abstract

3. Treatment and prognosis of brain metastases from breast cancer.

Author: Ogawa K; Yoshii Y; Nishimaki T; Tamaki N; Miyaguni T; Tsuchida Y; Kamada Y; Toita T; Kakinohana Y; Tamaki W; Iraha S; Adachi G; Hyodo A; Murayama S;
Institution: Department of Radiology, University of the Ryukyus School of Medicine, 207 Uehara, Nishihara-cho, Okinawa, Japan. kogawa@med.u-ryukyu.ac.jp
Journal: J Neurooncol. 2008 Jan;86(2):231-8. Epub 2007 Sep 12.
Abstract URL: Click here to view abstract

4. Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics?

Author: Curtis E; Quale C; Haggstrom D; Smith-Bindman R;
Institution: Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. e.curtis@auckland.ac.nz
Journal: Cancer. 2008 Jan 1;112(1):171-80.
Abstract URL: Click here to view abstract

5. Racial differences in pain during 1 year among women with metastatic breast cancer: a hazards analysis of interval-censored data.

Author: Castel LD; Saville BR; Depuy V; Godley PA; Hartmann KE; Abernethy AP;
Institution: Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA. liana@unc.edu
Journal: Cancer. 2008 Jan 1;112(1):162-70.
Abstract URL: Click here to view abstract

6. Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer.

Author: Dawson SJ; Price MA; Jenkins MA; McKinley JM; Butow PN; McLachlan SA; Lindeman GJ; Weideman P; Friedlander ML; Hopper JL; Phillips KA;
Institution: Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Locked Bag No. 1, A'Beckett St, Victoria, 8006, Australia.
Journal: J Clin Oncol. 2008 Jan 10;26(2):225-32. Epub 2007 Nov 26.
Abstract URL: Click here to view abstract

7. How important is the axillary nodal status for adjuvant treatment decisions at a breast cancer multidisciplinary tumor board? A survival analysis.

Author: Reimer T; Fietkau R; Markmann S; Stachs A; Gerber B;
Institution: Department of Obstetrics and Gynecology, University of Rostock, Klinikum Suedstadt, Suedring 81, 18059 Rostock, Germany. toralf.reimer@med.uni-rostock.de
Journal: Ann Surg Oncol. 2008 Feb;15(2):472-7. Epub 2007 Nov 7.
Abstract URL: Click here to view abstract

8. Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer.

Author: Burzykowski T; Buyse M; Piccart-Gebhart MJ; Sledge G; Carmichael J; Luck HJ; Mackey JR; Nabholtz JM; Paridaens R; Biganzoli L; Jassem J; Bontenbal M; Bonneterre J; Chan S; Basaran GA; Therasse P;
Institution: Hasselt University, Center for Statistics, Agoralaan, Bldg D, 3590 Diepenbeek, Belgium. tomasz.burzykowski@uhasselt.be
Journal: J Clin Oncol. 2008 Apr 20;26(12):1987-92.
Abstract URL: Click here to view abstract

9. Primary breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Author: Pestalozzi B; Castiglione M;
Institution: Klinik und Poliklinik fur Onkologie, Universitatsspital Zurich, Zurich, Switzerland.
Journal: Ann Oncol. 2008 May;19 Suppl 2:ii7-10.

10. Locally recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Author: Kataja V; Castiglione M;
Institution: Department of Oncology, Kuopio University Hospital, Kuopio, Finland.
Journal: Ann Oncol. 2008 May;19 Suppl 2:ii11-3.

11. Breast cancer in the previously augmented breast.

Author: McCarthy CM; Pusic AL; Disa JJ; Cordeiro PG; Cody HS 3rd; Mehrara B;
Institution: Department of Surgery, Plastic and Reconstructive Surgery Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. mccarthc@mskcc.org
Journal: Plast Reconstr Surg. 2007 Jan;119(1):49-58.
Abstract URL: Click here to view abstract

12. The Evolving Non-Surgical Ablation of Breast Cancer: MR Guided Focused Ultrasound (MRgFUS).

Author: Furusawa H; Namba K; Nakahara H; Tanaka C; Yasuda Y; Hirabara E; Imahariyama M; Komaki K;
Institution: Division of Breast Surgical Oncology, Breastopia NANBA Hospital.
Journal: Breast Cancer. 2007;14(1):55-8.
Abstract URL: Click here to view abstract

13. Physical Activity, Body Mass Index, and Mammographic Density in Postmenopausal Breast Cancer Survivors.

Author: Irwin ML; Aiello EJ; McTiernan A; Bernstein L; Gilliland FD; Baumgartner RN; Baumgartner KB; Ballard-Barbash R;
Institution: Department of Epidemiology and Public Health, Yale School of Medicine, New Haven, CT; Center for Health Studies, Group Health Cooperative; Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Preventive Medicine, University of Southern California, Los Angeles, CA; Cancer Research & Treatment Center, Department of Internal Medicine, University of New Mexico, Albuquerque, NM; and the Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD.
Journal: J Clin Oncol. 2007 Jan 29;.
Abstract URL: Click here to view abstract

14. Smoking and survival after breast cancer diagnosis.

Author: Holmes MD; Murin S; Chen WY; Kroenke CH; Spiegelman D; Colditz GA;
Institution: Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Journal: Int J Cancer. 2007 Feb 2;.
Abstract URL: Click here to view abstract

15. Breast tumours following combined hormone replacement therapy express favourable prognostic factors.

Author: Borgquist S; Anagnostaki L; Jirstrom K; Landberg G; Manjer J;
Institution: Department of Laboratory Medicine, Division of Pathology, Malmo University Hospital, Malmo, Sweden.
Journal: Int J Cancer. 2007 Feb 2;.
Abstract URL: Click here to view abstract

16. Risk of second non-hematological malignancies among 376,825 breast cancer survivors.

Author: Brown LM; Chen BE; Pfeiffer RM; Schairer C; Hall P; Storm H; Pukkala E; Langmark F; Kaijser M; Andersson M; Joensuu H; Fossa SD; Travis LB;
Institution: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Department of Health and Human Services, 6120 Executive Blvd, MSC 7244, Bethesda, MD, 20892-7244, USA, brownl@mail.nih.gov.
Journal: Breast Cancer Res Treat. 2007 Feb 3;.
Abstract URL: Click here to view abstract

17. Breast cancer patients' expectations in respect of the physician-patient relationship and treatment management results of a survey of 617 patients.

Author: Oskay-Ozcelik G; Lehmacher W; Konsgen D; Christ H; Kaufmann M; Lichtenegger W; Bamberg M; Wallwiener D; Overkamp F; Diedrich K; von Minckwitz G; Hoffken K; Seeber S; Mirz R; Sehouli J;
Institution: Charite Medical University, Augustenburger Platz 1, 13353 Berlin, Germany.
Journal: Ann Oncol. 2007 Feb 1;.
Abstract URL: Click here to view abstract

18. Relationship Between Number of Breast Cancer Operations Performed and 5-Year Survival After Treatment for Early-Stage Breast Cancer.

Author: Gilligan MA; Neuner J; Zhang X; Sparapani R; Laud PW; Nattinger AB;
Institution: Medical College of Wisconsin.
Journal: Am J Public Health. 2007 Jan 31;.
Abstract URL: Click here to view abstract

19. Multicenter Comparative Multimodality Surveillance of Women at Genetic-Familial High Risk for Breast Cancer (HIBCRIT Study): Interim Results.

Author: Sardanelli F; Podo F; D'Agnolo G; Verdecchia A; Santaquilani M; Musumeci R; Trecate G; Manoukian S; Morassut S; de Giacomi C; Federico M; Cortesi L; Corcione S; Cirillo S; Marra V;
Institution: 1 University of Milan School of Medicine, Department of Medical and Surgical Sciences, Unit of Radiology, IRCCS Policlinico San Donato, Via Morandi 30, 20097 San Donato Milanese, Milan, Italy.
Journal: Radiology. 2007 Jan 23;.
Abstract URL: Click here to view abstract

20. Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.

Author: Dowsett M; Smith IE; Ebbs SR; Dixon JM; Skene A; A'Hern R; Salter J; Detre S; Hills M; Walsh G;
Institution: Academic Department of Biochemistry, 4th Floor, Wallace Wing, The Royal Marsden Hospital, Fulham Road, London SW3 6 JJ, UK. mitch.dowsett@icr.ac.uk
Journal: J Natl Cancer Inst. 2007 Jan 17;99(2):167-70.
Abstract URL: Click here to view abstract

21. Leukemia following breast cancer: an international population-based study of 376,825 women.

Author: Howard RA; Gilbert ES; Chen BE; Hall P; Storm H; Pukkala E; Langmark F; Kaijser M; Andersson M; Joensuu H; Fossa SD; Travis LB;
Institution: Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Executive Plaza South, Suite 7091, Bethesda, MD, 20892, USA, reganho@mail.nih.gov.
Journal: Breast Cancer Res Treat. 2007 Jan 13;.
Abstract URL: Click here to view abstract

22. Changes in shoulder muscle size and activity following treatment for breast cancer.

Author: Shamley DR; Srinanaganathan R; Weatherall R; Oskrochi R; Watson M; Ostlere S; Sugden E;
Institution: Department of Physiotherapy, School of Health and Social Care, Oxford Brookes University, Jack Straws Ln, Marston, Oxfordshire, OX3 0FL, UK, drshamley@brookes.ac.uk.
Journal: Breast Cancer Res Treat. 2007 Jan 13;.
Abstract URL: Click here to view abstract

23. Thromboembolism and breast cancer: the hidden risk for patient and physician.

Author: Ursella S; Miele L; Pirronti T; Forgione A; Gasbarrini G; Silveri NG; Grieco A;
Institution: Department of Emergency Medicine, Catholic University of the Sacred Heart, Agostino Gemelli University Hospital, Rome, Italy.
Journal: Intern Med J. 2007 Feb;37(2):133-4.

24. Recurrences and second primary breast cancers in older women with initial early-stage disease.

Author: Geiger AM; Thwin SS; Lash TL; Buist DS; Prout MN; Wei F; Field TS; Ulcickas Yood M; Frost FJ; Enger SM; Silliman RA;
Institution: Division of Public Health Sciences, Department of Social Sciences and Health Policy, Wake Forest University Health Sciences, Winston-Salem, North Carolina.
Journal: Cancer. 2007 Jan 22;.
Abstract URL: Click here to view abstract

25. Estimating risk of breast cancer in carriers of BRCA1 and BRCA2 mutations: a meta-analytic approach.

Author: Fu R; Harris EL; Helfand M; Nelson HD;
Institution: Oregon Evidence-based Practice Center, Oregon Health & Science University, Portland, OR, U.S.A.
Journal: Stat Med. 2007 Jan 22;.
Abstract URL: Click here to view abstract

26. Individual differences in well-being in older breast cancer survivors.

Author: Perkins EA; Small BJ; Balducci L; Extermann M; Robb C; Haley WE;
Institution: School of Aging Studies, University of South Florida, 4202 East Fowler Avenue, MHC 1308, Tampa, FL 33612, United States.
Journal: Crit Rev Oncol Hematol. 2007 Jan 18;.
Abstract URL: Click here to view abstract

27. Bone mineral density in breast cancer patients with positive estrogen receptor tumor status.

Author: Douchi T; Yonehara Y; Kosha S; Iwamoto I; Rai Y; Sagara Y; Umekita Y;
Institution: Department of Obstetrics and Gynecology, Faculty of Medicine, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan.
Journal: Maturitas. 2007 Jan 18;.
Abstract URL: Click here to view abstract

28. The impact of age and clinical factors on quality of life in early breast cancer: An analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial).

Author: Hopwood P; Haviland J; Mills J; Sumo G; M Bliss J;
Institution: Christie Hospital NHS Trust, Wilmslow road, Withington, Manchester M20 4BX, UK.
Journal: Breast. 2007 Jan 18;.
Abstract URL: Click here to view abstract

29. Management of early breast cancer in the elderly.

Author: Rao VS; Garimella V; Hwang M; Drew PJ;
Institution: Academic Surgical Unit, University of Hull, Castle Hill Hospital, Cottingham, East Yorkshire, HU16 5JQ, United Kingdom.
Journal: Int J Cancer. 2007 Mar 15;120(6):1155-60.
Abstract URL: Click here to view abstract

30. Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations.

Author: Rennert G; Bisland-Naggan S; Barnett-Griness O; Bar-Joseph N; Zhang S; Rennert HS; Narod SA;
Institution: Clalit Health Services, National Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Technion, Haifa, Israel. rennert@tx.technion.ac.il
Journal: N Engl J Med. 2007 Jul 12;357(2):115-23.
Abstract URL: Click here to view abstract

31. Ovarian suppression for early breast cancer.

Author: Wilcken N; Stockler M;
Institution: Department of Medical Oncology, Westmead and Nepean Hospitals and University of Sydney, NSW 2145, Australia. nicholas_wilcken@wmi.usyd.edu.au
Journal: Lancet. 2007 May 19;369(9574):1668-70.

32. The impact of nodal isolated tumor cells on survival of breast cancer patients.

Author: Herbert GS; Sohn VY; Brown TA;
Institution: Department of Surgery, Madigan Army Medical Center, 9040A Reid St., Tacoma, WA 98431, USA. garth.herbert@gmail.com
Journal: Am J Surg. 2007 May;193(5):571-3; discussion 573-4.
Abstract URL: Click here to view abstract

33. Progesterone receptor status provides predictive value for adjuvant endocrine therapy in older estrogen receptor-positive breast cancer patients.

Author: Yu KD; Liu GY; Di GH; Wu J; Lu JS; Shen KW; Shen ZZ; Shao ZM;
Institution: Department of Breast Surgery, Cancer Hospital/Cancer Institute, Fudan University, Shanghai 200032, PR China.
Journal: Breast. 2007 Feb 9;.
Abstract URL: Click here to view abstract

34. Neoadjuvant therapy in locally advanced breast cancer: 99mTc-MIBI mammoscintigraphy is not a reliable technique to predict therapy response.

Author: Travaini LL; Baio SM; Cremonesi M; Cicco CD; Ferrari M; Trifiro G; Prisco G; Viale G; Colleoni MA; Radice D; Sivolapenko GB; Paganelli G;
Institution: Division of Nuclear Medicine, European Institute of Oncology, via Ripamonti 435, 20141 Milan, Italy.
Journal: Breast. 2007 Feb 7;.
Abstract URL: Click here to view abstract

35. Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first.

Author: Bollet MA; Sigal-Zafrani B; Mazeau V; Savignoni A; de la Rochefordiere A; Vincent-Salomon A; Salmon R; Campana F; Kirova YM; Dendale R; Fourquet A;
Institution: Department of Radiation Oncology.
Journal: Radiother Oncol. 2007 Feb 5;.
Abstract URL: Click here to view abstract

36. Personality and fatigue in patients with benign or malignant breast disease.

Author: Michielsen HJ; Van der Steeg AF; Roukema JA; De Vries J;
Institution: Department of Psychology and Health, Medical Psychology, Tilburg University, Room P510, P.O. Box 90153, 5000 LE, Tilburg, Netherlands.
Journal: Support Care Cancer. 2007 Feb 7;.
Abstract URL: Click here to view abstract

37. Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients.

Author: Hinnis AR; Luckett JC; Walker RA;
Institution: 1Department of Cancer Studies & Molecular Medicine, University of Leicester, Leicester Royal Infirmary, Leicester, LE2 7LX, UK.
Journal: Br J Cancer. 2007 Feb 6;.
Abstract URL: Click here to view abstract

38. Multidisciplinary frontiers in breast cancer management: a surgeon's perspective.

Author: Singletary SE;
Institution: Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.
Journal: Cancer. 2007 Feb 12;.
Abstract URL: Click here to view abstract

39. Association between pharmaceutical involvement and outcomes in breast cancer clinical trials.

Author: Peppercorn J; Blood E; Winer E; Partridge A;
Institution: Division of Hematology/Oncology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. jpepper@med.unc.edu
Journal: Cancer. 2007 Apr 1;109(7):1239-46.
Abstract URL: Click here to view abstract

40. BRCA1, a Potential Predictive Biomarker in the Treatment of Breast Cancer.

Author: James CR; Quinn JE; Mullan PB; Johnston PG; Harkin DP;
Institution: Centre for Cancer Research and Cell Biology, Queen's University Belfast, University Floor, Belfast City Hospital, Lisburn Road, Belfast BT9 7AB, Northern Ireland, U.K. d.harkin@qub.ac.uk.
Journal: Oncologist. 2007;12(2):142-150.
Abstract URL: Click here to view abstract

41. Risks for familial and contralateral breast cancer interact multiplicatively and cause a high risk.

Author: Hemminki K; Ji J; Forsti A;
Institution: Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany and Center for Family and Community Medicine, Karolinska Institute, Huddinge, Sweden.
Journal: Cancer Res. 2007 Feb 1;67(3):868-70.
Abstract URL: Click here to view abstract